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Summary
Objectives: To assess responsiveness and minimally important change (MIC) for the Manchester-Oxford foot questionnaire (MOXFQ) using
anchor and distribution-based approaches. Responsiveness and estimates of minimal clinically important difference (MCID) and minimal
detectable change are compared with those from the Short-Form 36 (SF-36) and American Orthopaedic Foot & Ankle Society (AOFAS)
measures.
Methods: A prospective observational study of 91 consecutive patients (125 foot operations) undergoing hallux valgus surgery at an ortho-
paedic hospital. Pre- and 12 month post-surgery, patients completed the MOXFQ and SF-36, and foot surgeons assessed all four AOFAS
scores corresponding to four regions of the foot. Transition items were asked about perceived changes compared with before surgery.
Results: Mean changes in all domains of each instrument were statistically signiﬁcant, but foot-speciﬁc MOXFQ and AOFAS domains pro-
duced much larger effect sizes (>1) than any SF-36 domains, indicating superior responsiveness. Clear associations occurred between tran-
sition items and all MOXFQ and AOFAS scores, but with only one (physical function) SF-36 domain. Anchor and distribution-based
approaches identiﬁed generally comparable measures of MIC, which for the MOXFQ and AOFAS domains were between 1 and 2 standard
error of measurement. In metric terms, the MCIDs were 16, 12, and 24 for the MOXFQ Walking/standing, Pain, and Social Interaction
domains, respectively.
Conclusions: For hallux valgus surgery, the MOXFQ is highly responsive. Performance is comparable to the AOFAS and notably better than
the generic SF-36. Study estimates of MIC for the MOXFQ are useful to inform sample-size calculations for future clinical trials.
ª 2007 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
Key words: Foot and ankle, Hallux valgus, Surgery, Quality of life, Outcomes assessment, Responsiveness, Minimal clinically important
differences.
International
Cartilage
Repair
SocietyIntroduction
Foot and ankle pain is very common, particularly in older
women1, being caused by many conditions2, including ar-
thritis3. A wide range of foot and ankle disorders are treated
surgically, with foot and ankle surgery constituting over 15%
of orthopaedic practice4. Many forms of foot and ankle sur-
gery have not, however, been adequately evaluated on ac-
count of the lack of appropriate, standardised methods of
outcomes assessment. In particular, there is a lack of
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sures devised with patients’ input and completed by them
and thus reﬂecting the patients’ not the clinicians’ perspec-
tive7,8. Bias is minimized by making assessment completely
independent of the surgical team9. Indeed, The Royal
College of Surgeons has recommended that validated
patient-reported outcome measures should be used, in
preference to clinical assessments, as the primary outcome
in clinical trials10.
One such patient-focused and patient-reported instru-
ment, the Manchester-Oxford foot questionnaire (MOXFQ)11,
has been developed for use as an outcome measure for all
types of foot surgery. We recently reported on the develop-
ment and initial assessment of the MOXFQ in patients
undergoing surgery for hallux valgus; a common condition,
affecting up to a third of the population1,12 and for which
clinical trials of surgical interventions for the condition are
urgently needed5,13.8
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responsiveness of an outcome measure, that is, its ability
accurately to detect change when it has occurred14, is
the most important aspect15. Nevertheless, while it is
simple to determine the statistical signiﬁcance of any
such changes, it can be harder to determine the real
clinical or subjective meaning of these changes, particu-
larly given the partial dependence of statistical signiﬁ-
cance on sample size. This problem can be largely
overcome if the minimally important change (MIC) is
known for the measure of interest16. The MIC can act
as a yardstick for clinical relevance, so that changes in
scores exceeding the MIC are known to be clinically
relevant17.
There are essentially two approaches to determining the
smallest amount of change on a measure that is likely to
be of importance. The ﬁrst approach is distribution based,
i.e., based on the statistical characteristics of the sample
under study. Examples include the effect size (ES), the
standardised response mean (SRM), the standard error
of measurement (S.E.M.), and the minimal detectable
change (MDC)16,18. The ES and SRM represent change
in standard deviation (SD) units, whereas the S.E.M. and
MDC are provided in the same units as the original mea-
surement. This method provides the smallest change
which, for an individual, is likely to be beyond the mea-
surement error of the instrument and thus to represent
a true change. However, it is not known whether this
change is clinically relevant. The second approach uses
anchor-based methods, where an external criterion is
used to provide an indication of the minimal change that
is of clinical relevance at the group level. The most com-
monly used such measure is the minimal clinically impor-
tant difference (MCID) which is deﬁned as the smallest
change in the measure that patients perceive as meaning-
ful and which would cause clinicians to consider a change
in the patient’s management19. Another measure is based
on diagnostic test methodology to give a best cut-point20.
The advantage of this approach is that the concept of
‘minimal importance’ is here explicitly deﬁned, which is
not the case with the former approach, although there
is no indication whether the change lies within the mea-
surement error of the instrument17. The two different
approaches are therefore different and unlikely to produce
identical results.
The purpose of the analyses reported in this paper is two-
fold: (1) to examine various forms of evidence for the re-
sponsiveness of the MOXFQ; and (2) to ascertain the
MIC for each of the three scales of the MOXFQ. In each
case, ﬁndings for the MOXFQ are compared with equivalent
results for the American Orthopaedic Foot & Ankle Society
(AOFAS) scores and the generic, patient-reported, Short-
Form 36 (SF-36).
Materials and methods
Local ethics committee approval was obtained (Applied
and Qualitative Research Ethics Committee reference
A02.009) and all subjects consented to participate in the
study.
SUBJECTS
Adult patients, aged between 20 and 75 years, were con-
secutively recruited from an orthopaedic hospital within 4
weeks prior to surgery for hallux valgus. Details of therecruitment procedures and sample size have been re-
ported elsewhere11.
ASSESSMENTS
Patients completed a pre-operative questionnaire, unas-
sisted, while attending a hospital pre-admission clinic. This
contained (1) demographic items, (2) the MOXFQ11d
completed separately for each foot to be operated on; and
(3) the SF-36 general health questionnaire21,22.
The MOXFQ11 (see Appendix 1) contains 16 items, each
with ﬁve response options, comprising three separate un-
derlying dimensions: foot pain (ﬁve items), walking/standing
problems (seven items) and issues related to social interac-
tion (four items), including feelings of self-consciousness
about foot/footwear appearance (‘cosmesis’). Item re-
sponses are each scored from 0 to 4, with 4 representing
the most severe state. The scale score representing each
dimension is produced by summing the responses to
each item within that dimension. Raw scale scores are
then converted to a metric (0e100; 100¼most severe).
The SF-36 contains 36 items and is widely used as a ge-
neric health status instrument. It provides scores on eight
dimensions of health: physical functioning, social function-
ing, role limitations due to physical problems, role limitations
due to emotional problems, mental health, energy/vitality,
bodily pain and general health perceptions over the last 4
weeks. Scores for each dimension are produced by sum-
ming the responses to each item within that dimension
and then converting the raw scores to a metric (0e100,
100¼ good health).
TheMOXFQ and SF-36 assessments were repeated in an
out-patient clinic setting 12 months post-surgery. Two addi-
tional ‘transition’ items were added on this occasion, asking
about perceived changes compared with before foot surgery
(see Table III for details) as well as three satisfaction items:
(1) ‘Overall, how pleased are you now with the result of
your surgery on your foot?’, (2) ‘Compared with before your
operation, how pleased are you with: (1) the appearance of
your foot?’, (2) the range of shoes that you can wear?’. Re-
sponse options to all three items were: ‘very pleased’, ‘fairly
pleased’, ‘not very pleased’, ‘very disappointed’.
In addition, the foot surgeon (a member of the Oxford and
Birmingham Foot and Ankle Clinical Research Group) com-
pleted pre- and 12 month post-surgical clinical examina-
tions using all four ratings of the standard AOFAS23.
These correspond to four regions of the foot: the ankle
and hindfoot, the midfoot, the hallux metatarsophalangeal
(MTP)einterphalangeal (IP) region and the lesser toe
MTPeIP region. The four domain scales are produced by
applying domain-speciﬁc weightings to individual item
scores and then summing the weighted item scores within
each domain. Thus, while some identical items appear in
more than one scale, they do not necessarily have the
same score weighting. Nonetheless, for each scale, the
minimum score is 0 and the maximum score 100, with
100 representing the best health. A score of 100 would be
obtained, for each scale, by a patient with no pain, full range
of motion, no instability, good alignment, no limitation of
daily or recreational activities, and no footwear limitations
for that particular foot region. The assessor was blinded to
patients’ responses to the other health status instruments.
Additional information was obtained pre-operatively, and
again at 3 months following surgery, concerning two mea-
sures of the hallux valgus deformity taken from routine ra-
diographs of the patient’s foot, using a goniometre: (1) the
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tween the longitudinal bisections of the ﬁrst metatarsal
and proximal phalanx, and (2) the ﬁrstesecond intermeta-
tarsal angle, measured as the angle formed between longi-
tudinal bisections of the ﬁrst and second metatarsal shafts.
Methods for taking these measurements have been illus-
trated elsewhere24, together with evidence of high inter-rater
reliability for the hallux abductus angle and intermetatarsal
angle. In our own study just one person (G.L.) provided
these measures.
STATISTICAL METHODS
Data analysis was undertaken within SPSS version
13.025 and STATA version 8.226. Data are presented as
mean (SD) at each assessment and mean change (SD)
from pre-admission to 12-months post-surgery, with paired
t tests being used to assess the statistical signiﬁcance of
any change. Continuous data were categorized where ap-
propriate. Statistical signiﬁcance was taken at the 5% level
throughout, with 95% conﬁdence intervals (CIs) used to ex-
press uncertainty around the estimates.
Comparative assessments of responsiveness and change
for each instrument were made using ES, relative efﬁciency,
MCID, best cut-point using diagnostic test methodology, and
MDC. All these measures are described below.
Responsiveness to change was ﬁrst assessed using ES
and overall relative efﬁciency. ES represents the extent of
change identiﬁed by an instrument in a unitless way so al-
lowing direct comparison between instruments27. The ES
is calculated by dividing the mean change in scores (post-
surgical minus pre-surgical scores), by the SD at time one
(pre-surgical score). An ES of 1.0 is thus equivalent to
a change of one SD in the sample. Values of 0.2, 0.5 and
0.8 are typically regarded as indicating small, medium and
large degrees of change27,28.
The overall relative efﬁciency (how efﬁcient one measure
is at capturing change relative to another measure) of the
MOXFQ vs (1) the AOFAS clinical assessment and (2)
the SF-36, was calculated by taking the square of the ratio
of the mean (over all scales within an instrument) of the in-
dividual paired t statistics comparing the baseline and 12
month follow-up scores29.
Non-parametric correlations (Spearman’s rho, rs)
30 were
used to examineassociationsbetween changescoresof clin-
ical (radiographically derived hallux abductus and intermeta-
tarsal angles and clinically assessed AOFAS scales), as well
as the patient-reported transition and satisfaction items. A
correlation coefﬁcient of 0.4e0.59 was taken to indicate
a moderate correlation and 0.6e0.79 a strong correlation.
Relationships between changes in the MOXFQ, AOFAS
and SF-36 scales between pre- and 12 months post-
surgery were further examined by comparing mean score
changes and ES in relation to different levels of response
to the patient-reported transition items at 12 months follow-
ing surgery. Patients who reported greater amounts of
change would be expected to have correspondingly greater
changes in outcome scores and associated larger ES if the
outcome measures were responsive. Analysis of variance
with tests for linear trend were used to assess the statistical
signiﬁcance and directionality of any association.
DISTRIBUTION-BASED MEASURES OF MIC
The distribution-based measures which were used to de-
termine important change were the S.E.M. and the MDC. TheS.E.M. is the error estimate for a single use of the question-
naire which is directly related to the reliability of the scale,
as indicated by Cronbach’s alpha (S.E.M.¼SD  O1 
Cronbach’s alpha). Cronbach’s Alpha was calculated using
the unweighted item scores of the MOXFQ, AOFAS and
SF-36 scales. Note that while total scale scores for each in-
strument range from 0 to 100, the AOFAS scales are pro-
duced by summation of individually weighted items, the
MOXFQ and SF-36 scales are produced by transformation
of the sum of individual unweighted items.
The MDC is deﬁned as the smallest amount of change
between two time points that indicates a real change in
the patient’s health status31, i.e., a change above that which
would be expected by chance alone. With a conventional
conﬁdence level of 90%, the MDC was calculated as
1.65  O2  S.E.M.. The interpretation of MDC90 is that
90% of truly stable patients will demonstrate random varia-
tion of less than this magnitude when assessed on multiple
occasions32.
ANCHOR-BASED MEASURES OF MIC
The MCID was determined for each of the MOXFQ,
AOFAS and SF-36 scales as the mean change scores
associated with a global rating of change (transition
item) of ‘slightly better’16. The MCID:S.E.M. ratio was cal-
culated for each scale and averaged over each instru-
ment to give an estimate of the relationship between
these two anchor and distribution-based approaches
and to compare its magnitude with that calculated in pre-
vious studies17.
In addition, an approach based on diagnostic test meth-
odology was also used20. Receiver operator characteristic
(ROC) curves were used to assess each of the MOXFQ,
AOFAS and SF-36 scales’ efﬁciency in differentiating be-
tween those who did and did not experience important clin-
ical change (‘Slightly better’/’much better’/‘no problems now’
vs ‘no change’/’worse’, respectively). ROC curves plot sen-
sitivity ( y-axis) against 1-speciﬁcity (x-axis) for all possible
cut-off points of the instrument. Sensitivity is deﬁned as
the number of patients that have improved (‘Slightly
better’/’much better’/‘no problems now’) divided by the num-
ber of all patients that have change scores above a cut-off
point. Speciﬁcity refers to the number of patients who have
not improved (‘no change’/’worse’) divided by the number of
all patients who have change scores below this cut-off
point. The most efﬁcient cut-off value, with regard to speci-
ﬁcity and sensitivity, is associated with the point closest to
the top left hand corner of the ROC curve. Since the best
cut-point ‘cuts’ or differentiates at the boundary between
improvement and no change, the best cut-point would be
expected to be lower than the value (the MCID) reported
by all subjects in the ‘slightly better’ group. In addition, the
greater the area under the ROC curve, the greater the
ability of the scale to differentiate between those who did
and did not have clinically important change. If the area
under the curve is 0.5, this represents a test that is not
predictive; the closer the area is to 1.0, the better the differ-
entiation of the scale31,33,34.
Results
STUDY POPULATION CHARACTERISTICS
The baseline study sample comprised 100 patients, rep-
resenting 138 feet (i.e. each foot¼ one ‘case’; 38 patients
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At baseline, the mean age of the patients was 50.03 (SD
12.9), median 52 years. Almost all (95%) were female.
Nine people (13 foot operations) had their surgery cancelled
or postponed, everyone else (91 patients, 125 cases) was
followed up 12 months post-surgery.
PROCEDURES
The majority of procedures (107, 85.6%) involved a scarf
osteotomy, while 13 (10.4%) were a chevron, and 5
(4.0%) other kinds of osteotomy. Eleven surgeons were
involved.
RADIOGRAPHIC DATA
The radiographic data, pre- and post-surgery, are shown
in Table I. Following surgery, there was a highly signiﬁcant
reduction in both the hallux abductus and intermetatarsal
angles (both P< 0.001).
RESPONSIVENESS OF THE MOXFQ
The mean pre- and 12 month post-operative scores (with
95% CIs) for the MOXFQ, AOFAS and SF-36 domains are
shown in Fig. 1, together with details of change scores (12
month score minus baseline score), paired t test compari-
sons and ES.
While mean changes on all domains were statistically
signiﬁcant (P< 0.001 for each MOXFQ and AOFAS
domain; P< 0.05 for each SF-36 domain) each of the
foot-speciﬁc domains produced much larger ES (all >1)
than any of the generic SF-36 domains, indicating supe-
rior responsiveness. In terms of ES, the hallux scale of
the AOFAS foot assessment appeared the most respon-
sive of the four clinical scales with an ES of 2.46. The av-
erage t statistics over all domains within each instrument
were 13.73, 12.40, and 4.10 for the MOXFQ, AOFAS
and SF-36, respectively, giving a relative efﬁciency of
the MOXFQ vs the AOFAS of 1.23 and vs the SF-36 of
11.21. Thus, while the MOXFQ was only slightly more
efﬁcient than the AOFAS, it was much more efﬁcient
than the SF-36.
The correlations (rs) between radiographic measures
(hallux abductus and intermetatarsal angles), MOXFQ,
SF-36, the clinical assessment AOFAS domains and the
transition and satisfaction items are shown in Table II.
Correlation coefﬁcients that were at least moderate
(rs> 4.0) have been highlighted. The key ﬁnding here is
that changes in measures of hallux valgus severity taken
from radiographs did not correlate with any other mea-
sure. In addition, changes on the foot-speciﬁc (MOXFQ
and AOFAS) measures were generally much more highly
correlated (rs  0.5) with each other than with changes inthe SF-36 domains, with the exception of the SF-36 phys-
ical function scale, with which they were generally moder-
ately correlated (0.4< rs< 0.5). In terms of the transition
items, the MOXFQ pain scale and the AOFAS hallux
and AHF scales were all moderately, but highly signiﬁ-
cantly, correlated (rs¼ 0.5, P< 0.001) with the transition
item concerning change in pain. In addition, the MOXFQ
pain scale was moderately correlated (rs¼ 0.48) with the
transition item concerning change in foot-related prob-
lems, and the MOXFQ social interaction scale was mod-
erately correlated (rs¼ 0.44) with the satisfaction item
concerning the range of shoes that could be worn post-
surgery. No SF-36 domain had any more than low corre-
lation with changes in the transition and satisfaction
items.
The relationships between the changes in MOXFQ,
AOFAS and SF-36 domain scores and the patient-reported
transition item concerning perceived change in foot-related
problems at 12 months following surgery, in terms of mean
changes and ES, are shown in Table III.
For the foot-speciﬁc measures (MOXFQ and AOFAS),
there were clear associations between domain scores and
global judgement of change, with statistically signiﬁcant lin-
ear trends for increasing degree of improvement in domain
score with greater degree of perceived improvement. By
contrast, changes in the generic SF-36 domains, with the
exception of scores on the physical function domain,
showed almost no association with levels of response on
this transition item.
ANCHOR-BASED MEASURES OF MIC
Minimal clinically important difference
The MCID estimates for the three MOXFQ domains of
Walking/standing, Pain, and Social Interaction were 12.8,
4.6, and 20.3, respectively, with ES of 0.4, 0.2, and 0.8
(Table III). The ES were similar for the AOFAS scales
with the exception of the Hallux scale which had an MCID
with a notably larger ES of 2.0. While the MCIDs can be es-
timated for the SF-36 domains, because there is no trend in
mean change scores across the transition item responses
these estimates cannot be regarded as reliable.
Best cut-point using diagnostic test methodology
Examples of the ROC curves for the MOXFQ domains
are shown in Fig. 2. These are based upon patients’
responses (‘Slightly better/much better/no problems’ vs
‘no change/worse’) to the transition item concerning foot-
related problems at 12 months following foot surgery.
Table IV summarises the results of all ROC curves,
showing the area under the curve (with 95% CIs) andTable I
Pre- and post-surgical hallux abductus and intermetatarsal angles, measured from radiographs. Data are shown as mean (SD) degrees
Angle Pre-surgery Post-surgery Change P-value
Hallux abductus 35.44 (8.96) range 18 to 60 17.93 (8.52) range 0 to 40 17.51 (10.24) <0.001
Range 3.00 to 45.00
95% CI 15.6, 19.4
Intermetatarsal 15.26 (3.45) range 2 to 30 9.03 (2.76) range 0 to 18 6.24 (3.41) <0.001
Range 8.00 to 17.00
95% CI 5.61, 6.86
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Social Interaction
pre post
Walking/standing Pain Social interaction 
Pre, mean (sd) 44.9 (25.4) 52.7 (20.1) 46.6 (23.0)
Post, mean (sd) 16.4 (23.1) 19.9 (20.9) 11.8 (18.7)
Change, mean (sd) -28.5 (27.6) -32.8 (25.1) -34.8 (24.1)
Paired t (p-value) 11.3 (<0.001) 14.1 (<0.001) 15.8 (<0.001)
Effect size 1.12 1.63 1.51
Halux MTP-IP Ankle hindfoot Midfoot Lesser toe MTP-IP
Pre, mean (sd) 54.8 (11.9) 75.3 (10.4) 68.1 (12.2) 61.4 (14.5)
Post, mean (sd) 84.2 (15.0) 90.0 (11.1) 86.1 (12.6) 79.8 (18.4)
Change, mean (sd) 29.4 (16.8) 14.7 (14.0) 18.0 (15.8) 18.4 (18.0)
Paired t (p-value) 18.1(<0.001) 10.4(<0.001) 11.3(<0.001) 9.9(<0.001)
Effect size 2.46 1.42 1.48 1.27
Physical
function
Role
Physical Role mental 
Social
functioning
Mental
health
Energy/
Vitality Pain
General
health
Pre, mean (sd) 75.0 (22.6) 75.1 (27.0) 83.0 (23.2) 78.3 (23.3) 70.6 (17.0) 57.3 (20.4) 61.6 (24.4) 76.2 (19.4)
Post, mean (sd) 85.3 (18.7) 85.5 (24.7) 91.0 (18.4) 84.9 (21.3) 77.5 (16.3) 62.5 (18.1) 77.2 (21.2) 79.6 (17.2)
Change,mean (sd) 10.3 (19.2) 10.4 (31.0) 7.99 (25.5) 6.6 (25.4) 6.9 (14.4) 5.2 (17.9) 15.6 (26.6) 3.5 (14.9)
Paired t (p-value) 5.6 (<0.001) 3.7 (<0.001) 3.4 (0.001) 2.8 (0.006) 5.3 (<0.001) 3.2 (0.002) 6.4 (<0.001) 2.5 (0.015)
Effect size 0.45 0.39 0.34 0.28 0.41 0.25 0.64 0.18 
Fig. 1. Mean pre- and 12 month post-operative scores, change scores, ES and paired t test comparisons for the patient-reported MOXFQ and
clinical AOFAS foot-speciﬁc assessment scales together with those from the generic SF-36 scale.
Table II
Correlation (Spearman’s rho) between change scores, comparing radiographic measures (hallux abductus and intermetatarsal angles), clinical assessment (AOFAS hallux, ankle-hindfoot,
general health perception scales) and MOXFQ
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71.0-
30.0-
81.0-
70.0
50.0
200.0-
40.0
20.0
40.0-
01.0
40.0
60.0
90.0
01.0
61.0
10.0
90.0
90.0
21.0
21.0
73.0
80.0-
90.0-
41.0-
40.0
80.0
90.0-
80.0-
31.0-
11.0-
21.0-
70.0-
10.0-
50.0-
30.0
31.0
70.0
61.0
11.0
60.0
**72.0
10.0-
60.0
*63.0-
*86.0-
*63.0-
*93.0
61.0
80.0
90.0
61.0
31.0
*52.0
11.0
*98.0
*48.0
*09.0
*54.0
*63.0
81.0
*22.0
*43.0
70.0-
40.0
*12.0-
70.0-
60.0-
***04.0
***25.0
**92.0
***04.0
***73.0
**62.0
**82.0
11.0
50.0-
70.0-
70.0
01.0-
90.0
90.0-
30.0
70.0-
21.0-
01.0
***44.0-
***43.0-
**72.0-
***35.0
***55.0
71.0
***04.0
51.0
*81.0
**82.0
*52.0
***93.0
***63.0
**72.0
10.0-
*91.0
20.0
10.0-
41.0
11.0-
40.0-
70.0-
50.0-
90.0
91.0
**92.0
***53.0
***14.0
***73.0
*81.0
**62.0
31.0
70.0
60.0
31.0
21.0-
20.0
61.0-
100.0
40.0-
31.0-
20.0
11.0-
11.0-
60.0-
**52.0
*22.0
***43.0
***83.0
***73.0
51.0
***73.0
61.0
41.0
11.0
41.0
20.0
60.0
20.0
*81.0
50.0
80.0-
40.0
***04.0-
*22.0-
*91.0-
***55.0
***86.0
***65.0
***83.0
***14.0
***04.0
***04.0
90.0
*12.0
12.0
11.0
20.0-
70.0
80.0
61.0
51.0
90.0-
200.0-
*02.0-
51.0-
70.0-
***43.0
***54.0
***65.0
***43.0
***53.0
71.0
**92.0
80.0
*22.0
81.0
01.0
61.0-
80.0-
40.0-
21.0
01.0-
80.0
50.0
***64.0-
*42.0-
**92.0-
***36.0
***54.0
***86.0
*22.0
**92.0
***55.0
***25.0
61.0
***63.0
**33.0
*12.0
80.0-
41.0
70.0-
100.0
90.0
40.0
70.0
***26.0-
***74.0-
***64.0-
***36.0
***43.0
***55.0
**52.0
91.0
***35.0
***04.0
***93.0
***74.0
***34.0
***04.0
90.0
*12.0
51.0
80.0
**72.0
41.0-
81.0-
***94.0
***24.0
***64.0-
**92.0-
70.0-
*91.0-
60.0-
90.0
**72.0-
60.0-
***63.0-
***34.0-
***73.0-
**92.0-
**13.0-
***73.0-
71.0-
91.0-
***44.0-
Correlations that are at least moderate (r> 4.0) have been highlighted. *P< 0.05; **P< 0.01; ***P< 0.001.
Co ent levels of response to a patient-reported
ity
Tra ale change
Ho
you
bef
Midfoot Lesser toe MTPeIP
Mean (SD) [ES] Mean (SD) [ES]
No n¼ 32 n¼ 28
21.38 (12.47)
[1.86]
23.75 (13.69)
[1.74]
Mu n¼ 47 n¼ 47
20.66 (14.57)
[1.71]
20.21 (18.01)
[1.33]
Slig n¼ 11 n¼ 10
8.36 (11.16)
[0.85]
12.80 (12.97)
[1.02]
No n¼ 6 n¼ 11
1.67 (28.80)
[0.10]
1.86 (24.99)
[0.11]
To n¼ 96 n¼ 92
18.30 (15.65)
[1.50]
18.80 (17.96)
[1.29]
P-v 0.001 0.001
Tra
Ho
you
bef
lity Pain General health
[ES] Mean (SD) [ES] Mean (SD) [ES]
No n¼ 41 n¼ 40
3) 23.04 (24.52)
[1.00]
5.32 (11.94)
[0.38]
Mu n¼ 59 n¼ 53
4) 12.05 (27.93)
[0.51]
2.83 (14.17)
[0.13]
Slig n¼ 12 n¼ 12
5) 15.74 (21.43)
[0.56]
6.67 (17.99)
[0.32]
No n¼ 7 n¼ 7
4) 1.59 (27.54)
[0.06]
8.43 (24.72)
[0.37]
To n¼ 119 n¼ 112
9) 15.59 (26.57)
[0.64]
3.46 (14.86)
[0.18]
P-v 0.034 0.114
where missing items occurred on either the
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6Table III
mparison of mean changes (with SDs) and ES, comparing the foot-specific MOXFQ and AOFAS, and generic SF-36 scales in relation to differ
transition item about foot-related problems at 12 months following surgery to correct hallux valgus deform
nsition item MOXFQ scale change AOFAS sc
w are the problems related to
r foot now, compared with
ore surgery?
WS Pain SI Hallux MTPeIP Ankle hindfoot
Mean (SD) [ES] Mean (SD) [ES] Mean (SD) [ES] Mean (SD) [ES] Mean (SD) [ES]
problems now n¼ 40* n¼ 39 n¼ 43 n¼ 34 n¼ 31
37.23 (25.34)
[1.40]
43.46 (21.2)
[2.04]
42.79 (21.15)
[2.02]
35.12 (10.74)
[3.44]
18.16 (9.68)
[1.91]
ch better n¼ 59 n¼ 58 n¼ 59 n¼ 51 n¼ 47
31.96 (23.42)
[1.46]
36.21 (20.38)
[1.89]
36.33 (21.70)
[1.56]
30.59 (16.06)
[2.47]
17.28 (13.08)
[1.63]
htly better n¼ 12 n¼ 11 n¼ 12 n¼ 12 n¼ 10
12.80 (18.43)
[0.39]
4.55 (15.2)
[0.20]
20.31 (19.42)
[0.79]
22.17 (15.28)
[2.00]
4.70 (7.09)
[0.59]
change/worse n¼ 9 n¼ 9 n¼ 9 n¼ 7 n¼ 6
12.30 (32.05)
[0.43]
1.11 (26.90)
[0.07]
9.03 (33.09)
[0.38]
8.29 (28.63)
[0.51]
3.17 (25.83)
[0.22]
tal n¼ 120 n¼ 117 n¼ 96 n¼ 104 n¼ 94
28.48 (27.58)
[1.12]
32.78 (25.09)
[1.63]
34.77 (24.06)
[1.51]
29.60 (16.81)
[2.46]
14.93 (13.94)
[1.43]
alue for linear trend <0.001 <0.001 <0.001 <0.001 <0.001
nsition item SF-36
w are the problems related to
r foot now, compared with
ore surgery?
Physical function Role physical Role mental Social function Mental health Energy/vita
Mean (SD) [ES] Mean (SD) [ES] Mean (SD) [ES] Mean (SD) [ES] Mean (SD) [ES] Mean (SD)
problems now n¼ 36 n¼ 41 n¼ 40 n¼ 40 n¼ 41 n¼ 41
10.56 (14.43)
[0.55]
12.80 (23.51)
[0.53]
5.83 (22.58)
[0.28]
6.25 (28.02)
[0.32]
8.05 (15.77)
[0.49]
5.64 (17.3
[0.34]
ch better n¼ 56 n¼ 58 n¼ 59 n¼ 57 n¼ 60 n¼ 59
15.36 (19.28)
[0.65]
12.07 (31.89)
[0.45]
8.76 (24.39)
[0.40]
8.77 (23.26)
[0.37]
7.25 (13.39)
[0.42]
4.45 (19.1
[0.22]
htly better n¼ 9 n¼ 12 n¼ 12 n¼ 12 n¼ 12 n¼ 12
2.78 (20.02)
[0.10]
8.85 (38.11)
[0.30]
2.78 (24.19)
[0.15]
1.04 (25.82)
[0.04]
2.08 (12.15)
[0.14]
3.65 (13.4
[0.14]
change/worse n¼ 8 n¼ 9 n¼ 9 n¼ 7 n¼ 9 n¼ 9
18.13 (8.43)
[1.20]
9.03 (42.75)
[0.33]
26.85 (38.14)
[0.76]
0.0 (28.87)
[0]
5.56 (18.10)
[0.35]
9.72 (19.0
[0.61]
tal n¼ 109 n¼ 120 n¼ 120 n¼ 116 n¼ 122 n¼ 121
10.28 (19.21)
[0.45]
10.42 (31.02)
[0.39]
7.99 (25.48)
[0.34]
6.57 (25.40)
[0.28]
6.89 (14.41)
[0.41]
5.17 (17.8
[0.25]
alue for linear trend 0.001 0.110 0.206 0.522 0.343 0.794
*The ‘n’ in each cell varies slightly across the rows reﬂecting an occasional missing patient’s response to an item within the health status scale, or
- or post-operative clinical assessment (hence the particular overall scale would not have been computed for that individual).
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Fig. 2. ROC curves differentiating pain ‘at least slightly better’ from ‘no change/worse’ with best cut-point indicated (with an arrow) on the
walking/standing, pain and social interaction scales of the MOXFQ.best scale cut-points for both transition items. Scales having
an area with 95% CIs not overlapping the value of 0.5
(therefore providing statistically signiﬁcant prediction) have
been highlighted. Based on the area under the curve, allthree MOXFQ scales showed great ability to differentiate
between patients reporting improvement vs no improve-
ment/worse, both in terms of pain and foot-related prob-
lems. All four AOFAS scales performed well in terms of
926 J. Dawson et al.: Responsiveness and MCID for MOXFQ, AOFAS and SF-36Table IV
A comparison of ROC and best scale cut-points for the MOXFQ, AOFAS assessment and SF-36 scales, based upon responses: ‘Slightly
better/much better/no problems’ vs ‘no change/worse’, to transition items about foot pain and foot-related problems, at 12 months following
foot surgery
ROC area Best cut point 
Pain group Problems Pain group Problems
MOXFQ 
WS 0.82 (.71–.94) 0.87 (.73–.99) –14.29 –14.29
   Pain 0.89 (.80–.97) 0.86 (.74–.99) –25.0 –25.0
SI 0.81 (.66–.95) 0.82 (.62–1.0) –25.0 –18.75
AOFAS 
Hallux MTP–IP 0.85 (.69–1.0) 0.80 (.54–1.0)  17.0 7.0
   Ankle hindfoot 0.87 (.70–1.0) 0.81 (.50–1.0) 2.0 2.0
   Midfoot 0.86 (.69–1.0) 0.77 (.46–1.0) 5.0 5.0
Lesser toe MTP–IP 0.83 (.67–.99) 0.81 (.55–1.0) 7.0 3.0
SF–36
   Physical function 0.75 (.58–.93) 0.96 (.93–1.0) 5.0  10.0
   Role physical 0.65 (.48–.82) 0.72 (.48–.96)  25.0  25.0
   Role mental 0.48 (.32–.64) 0.34 (.13–.54)
   Social function 0.60 (.41–.78) 0.60 (.32–.89)  12.5
   Mental health 0.56 (.37–.74) 0.50 (.26–.74) 5.0
12.5
5.0
   Energy/vitality 0.37 (.24–.51) 0.45 (.24–.66)
   Pain 0.63 (.49–.78) 0.68 (.46–.91) 0  11.1
   General health 0.65 (.47–.83) 0.65 (.37–.93)  10.0  10.0
Area under the curve: value 1.0¼ perfectly predictive, 0.5¼ no better than chance (excessive noise), 0.0¼ consistently incorrect. Values
with conﬁdence limits >0.5 have been highlighted.differentiating between patients according to responses
concerning pain, but CIs for the area under the curve
were all much wider and, in the case of hindfoot and
midfoot scales, crossed 0.5 in relation to foot-related prob-
lems. This indicated superior performance of the MOXFQ
compared with the AOFAS in this regard. The SF-36
performed poorly in this analysis, with only the physical
function domain achieving a reasonable area under the
curve; the 95% CIs for the other domains crossed 0.5 and
the sensitivity for all domains, including physical function,
was low.
In terms of the pain transition item, best cut-points for the
MOXFQ suggested that a change of 14 scale points for the
walking/standing scale and 25 points for the pain and social
interaction scales indicate a minimally important amount of
change. Best cut-points for the AOFAS scales were 17
points for the hallux MTP-IP scale and 7 for the lesser toe
MTP-IP scale; while for the SF-36 physical function domain
the best cut-point was 5 scale points.
Comparison of the two anchor-based approaches
The best cut-point and MCID for each domain are shown
in Table V. While the best cut-point is lower than the MCID
only for the MOXFQ walking/standing scale, this is true of
all AOFAS scales. This reﬂects the shallower ROC curves
for the MOXFQ than for the AOFAS, with the MOXFQ
thus providing poorer discrimination between patients re-
porting improvement vs no change. Nevertheless, the
sensitivity and speciﬁcity of all domains in both instruments
are high at between 70% and 80%. This contrasts with the
domains of the generic SF-36 which all have low levels of
sensitivity and which have best cut-points (where these
could be calculated) greater than the MCID for most do-
mains, with the exception of that for the Physical Function
domain.DISTRIBUTION-BASED MEASURES OF MINIMAL IMPORTANT
CHANGE
TheCronbach’s alpha, S.E.M., andMDC90% for each scale
within each instrument are shown in Table V. TheCronbach’s
alpha (representing internal reliability) was satisfactory
(>0.7) or optimal (range 0.80e0.90)35,36 for all MOXFQ and
SF-36 domains, but for none of the AOFAS scales.
The error associated with a single use of the question-
naire, the S.E.M., is estimated as approximately 7, 8, and
12 scale points for the MOXFQ Walking/standing, Pain,
and Social interaction scales, respectively. The MDC
90%, the value beyond which real change in the patient’s
health status is likely to have occurred, is estimated as
12, 15, and 20 for the three scales. These ﬁgures are com-
parable to the estimates for the SF-36 domains but are
larger than those for the AOFAS scales.
COMPARISON OF THE MEASURES OF MIC FROM THE
ANCHOR AND DISTRIBUTION-BASED APPROACHES
The results of the distribution (Cronbach’s alpha, S.E.M.,
MDC) and anchor-based (MCID and ROC best cut-point to-
gether with its sensitivity and speciﬁcity) approaches to as-
sessing MIC are shown in Table V for all the MOXFQ,
AOFAS and SF-36 scales. The MCID:S.E.M. ratio is also
shown.
The values for the SF-36 do not show good agreement be-
tween the two approaches, this is consistent with the gener-
ally low responsiveness and discrimination shown by this
generic measure. Nevertheless, the MDC values are gener-
ally smaller than the MCID values for most domains within
the two disease-speciﬁc measures, with the exception of
the MOXFQ pain domain. This indicates consistency be-
tween the anchor and distribution-based approaches in the
estimation of meaningful change since the MCID should
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Cronbach’s alpha scores and values (percentage scores) representing scaled S.E.M. and MDC for the MOXFQ, AOFAS and SF-36 scales. The
MCID, in terms of those reporting their pain to be ‘slightly better’ at 12 months following foot surgery compared with before surgery is also
shown, together with the MCID:S.E.M. ratio, and (differentiating between those who said their pain was ‘Slightly better/much better/no pain
now’ vs ‘no change/worse) the area under the ROC, the best cut-point, and values of sensitivity and specificity
Distribution-based approaches Anchor-based approaches
Cronbach’s
a
Scaled
S.E.M
Scaled
MDC 90%
MCID
‘‘slightly better’’
MCID/
S.E.M.
ROC area
(95% CI)
Best
cut-point
Sensitivity Speciﬁcity
MOXFQ
WS 0.92 7.38 11.98 16.07 2.18 0.82 (0.71e0.94) 14.29 78.1 73.3
Pain 0.86 8.10 14.85 11.82 1.46 0.89 (0.80e0.97) 25.0 76.5 86.7
SI 0.73 11.92 20.14 23.96 2.01 0.81 (0.66e0.95) 25.0 73.1 80.0
AOFAS
Hallux MTPeIP 0.63 9.26 7.10 24.75 2.67 0.85 (0.69e1.0) 17.0 75.0 87.0
Ankle hindfoot 0.57 7.30 6.30 8.90 1.22 0.87 (0.70e1.0) 2.0 90.9 92.8
Midfoot 0.59 8.34 6.74 12.40 1.49 0.86 (0.69e1.0) 5.0 81.8 88.2
Lesser toe MTPeIP 0.61 9.30 7.12 11.33 1.21 0.83 (0.67e0.99) 7.0 72.7 87.7
SF-36
Physical function 0.88 7.74 14.52 12.78 1.65 0.75 (0.58e0.93) 5.0 64.3 82.1
Role physical 0.95 6.08 14.38 22.92 3.77 0.65 (0.48e0.82) 25.0 40.0 89.5
Role mental 0.94 5.86 16.30 4.86 0.83 0.48 (0.32e0.64) e e e
Social function 0.86 8.70 24.33 7.29 0.84 0.60 (0.41e0.78) 12.5 38.5 81.6
Mental health 0.81 7.34 14.14 4.48 0.61 0.56 (0.37e0.74) 5.0 40.0 84.1
Energy/vitality 0.85 7.72 16.21 3.65 0.47 0.37 (0.24e0.51) e e e
Pain 0.82 10.28 24.93 20.35 1.98 0.63 (0.49e0.78) 0 61.5 61.3
General health 0.80 8.43 15.15 9.58 1.14 0.65 (0.47e0.83) 10.0 53.9 87.9ideally be greater than the MDC to enable its detection. The
MCID estimates are, for the two disease-speciﬁc measures,
on average around 1.8 times the S.E.M. (an average of 1.9 for
the MOXFQ domains and 1.7 for the AOFAS domains).
Discussion
In this paper we have been able to demonstrate excellent
responsiveness of both the MOXFQ and the AOFAS and,
within these instruments, good agreement between the
two approaches for estimating MIC. The generic SF-36
did not perform as well as the two disease-speciﬁc
measures.
In terms of the practical uses of the measures calcu-
lated in this study, the MCID represents the mean
change score of those patients who report feeling at
least slightly better, whereas the best cut-point is the
score above which patients are deemed to have at least
slightly improved. The best cut-point may be used to de-
termine, post hoc, whether an individual has, in terms of
their response to the instrument, clinically signiﬁcantly im-
proved, while the MCID would be used, a priori, in calcu-
lating sample size. Any particular study should be large
enough to have sufﬁcient power (i.e., 80%) of detecting
at certain alpha levels (e.g., P< 0.05) the MCID value,
i.e., the smallest change patients consider to be mean-
ingful. The results reported here are thus likely to be of
beneﬁt to those using and interpreting outcome mea-
sures in clinical practice, planning clinical trials and, in
consultation with a statistician, in performing sample-
size calculations.
RESPONSIVENESS
In terms of responsiveness and ES, it is important to
note that the ES is not a property of a method of assess-
ment but rather of the treatment intervention, and that it isinﬂuenced by the type of intervention, the amount of time
from the intervention to the assessment and by the patient
population37. Nevertheless, both of the foot-speciﬁc mea-
sures (MOXFQ and AOFAS) exhibited high levels of re-
sponsiveness that were superior to all domains of the
generic SF-36. While the hallux scale of the AOFAS foot
assessment appeared the most responsive overall, the
summary measure of relative efﬁciency suggested that
the MOXFQ was slightly more efﬁcient than the AOFAS.
Furthermore, for these two foot-speciﬁc measures, there
were clear associations between domain scores and pa-
tients’ global judgements of change in their foot pain and
foot-related problems, while, with the exception of the
physical function domain, this was generally not the case
for the SF-36.
Neither of the radiographic measures of hallux valgus
severity correlated with any measure of outcome, as also re-
ported elsewhere38 suggesting that radiographic measures
are of limited use in the assessment of outcomes of hallux
valgus surgery. A lack of correspondence between radio-
graphic changes and peoples’ symptoms has also been
noted in other areas of orthopaedics, e.g., osteoarthritis of
the hip and knee39,40.
ANCHOR-BASED MEASURES OF MIC
The two speciﬁc measures were strongly, and linearly, re-
lated to the global transition items, enabling estimation of
the MCID within those patients reporting that they felt
‘slightly better’. These MCID estimates were equivalent to
ES of 0.4, 0.2, and 0.8 (an average of 0.5) in the MOXFQ
walking/standing, pain, and social interaction scales, re-
spectively. In general, the ES were higher in the AOFAS,
particularly in the highly speciﬁc hallux scale. Nevertheless,
the ability of the different measures to differentiate between
patients reporting different levels of improvement on
transition, using ROC curves, indicated that the MOXFQ
928 J. Dawson et al.: Responsiveness and MCID for MOXFQ, AOFAS and SF-36performed better than the AOFAS, while both of the foot-
speciﬁc measures outperformed the SF-36 to a consider-
able degree.
COMPARISON OF ANCHOR AND DISTRIBUTION-BASED
ESTIMATES OF MIC
The anchor and distribution-based approaches provided
similar estimates of meaningful change, suggesting that
for both foot-speciﬁc measures the MCID is around 1.8
times the S.E.M. This accords with estimates from a previous
review of the relation between the MCID and S.E.M. in pa-
tients with chronic disease (a 1 S.E.M. correspondence)
and back, lower neck and extremity pain (an approximately
2.3 correspondence)41. This concordance is important as
the S.E.M. incorporates both the reliability and the variability
of a measure. Agreement between the patient-reported
MCID and the more mathematically derived S.E.M., and the
MDC derived from it, gives weight to the relevance of the
MCID in representing meaningful change.
It has previously been suggested that a one-S.E.M. crite-
rion (or, equivalently, 0.5 SD when the reliability of the in-
strument is 0.75) can be used as a proxy for MIC in the
interpretation of all health related quality of life instru-
ments42. However, since the S.E.M. is simply a measure of
detectable change it is more likely that this one-S.E.M. crite-
rion is one for minimally detectable change than MIC17. The
ﬁnding in this study that the MCID is, on average, 1.8 S.E.M.s
is consistent with this and supports the validity of these
MCID estimates.
MEASUREMENT PROPERTIES OF THE INSTRUMENTS
These ﬁndings provide strong support for the validity and
responsiveness (and responsiveness is itself one indication
of a measure’s validity43) of both the disease-speciﬁc
MOXFQ and AOFAS measures, suggesting that they per-
form well in patients undergoing hallux valgus surgery. All
scales within these measures performed better (with greater
precision) than the SF-36 in distinguishing between patients
who gave different ratings of global change in their foot symp-
toms and satisfaction following surgery for hallux valgus.
However, while the generic SF-36 was much less efﬁcient
overall than either of the two disease-speciﬁc measures, the
physical function and pain domains showed a statistically
signiﬁcant linear trend for greater degree of change with
greater perceived improvement, and overall, the SF-36
physical domains performed better in patients receiving sur-
gery for hallux valgus than the emotional domains.
Our evidence strongly suggests that a previous study,
which also found little association between the SF-36 and
the AOFAS, reached an erroneous conclusion in declaring
the construct validity of the AOFAS to be poor44, when it
was the construct validity of the SF-36 in the specific context
of foot surgerywhichwas likely to be themore questionable in
their study, theSF-36not beingdesigned toassess foot or an-
kle problems speciﬁcally, would therefore not be expected to
perform with a high degree of responsiveness in the context
of hallux valgus surgery and should not be used as the pri-
mary outcome measure in this context (as others have
noted45). By contrast, the AOFAS clinical domains were
designed speciﬁcally to assess foot or ankle problems and
are very widely used for this purposeddespite the limited
evidence, until now, for their reliability, validity or
responsiveness45.
Indeed, in addition to the stated aims of the paper, this
study has provided evidence concerning the measurementproperties of the four scales of the AOFAS clinical assess-
ment. Here, the Cronbach’s alpha (representing internal re-
liability) was less than satisfactory (<0.7) for all domains of
the AOFAS35,36. However, the meaning of the Cronbach’s
alpha is difﬁcult to interpret in relation to the AOFAS do-
mains in view of the overlap and differences in scoring
that are applied to some identical items contained in all
four scales. Furthermore, the fact that some items are ge-
neric, being used in the calculation of all four scale scores,
and others speciﬁc to that particular foot region may result
in relatively lower levels of internal reliability. However,
since power is a function of reliability and sample size,
a less reliable instrument can achieve sufﬁcient power if
the sample size is increased37.
CLINICAL IMPLICATIONS OF THE FINDINGS
Those wishing to investigate outcomes of foot and ankle
surgical interventions have to choose which outcome mea-
sure(s) are the most appropriate to use. An important con-
sideration is the measurement properties of the different
measures being considered. We have here provided such
details representing a few candidate measures, focusing
mainly on the properties of the MOXFQ. However, other
considerations are also of importance. Speciﬁc measures
are less prone to interferencedor ‘noise’dfrom other con-
ditions than are generic measures (e.g., the SF-36), al-
though it is unrealistic to imagine that all noise can be
eradicated46. The addition of a standard clinical assess-
ment may add useful information to the overall assessment
process, although the pros and cons of adding other mea-
sures need to be weighed carefully, as there tends to be
a trade-off between the amount of data that is collected
and the completeness of the data obtained.
In conclusion, the MOXFQ, devised with input from pa-
tients undergoing foot surgery, has previously been demon-
strated to have very favourable measurement properties in
terms of its reliability and validity11. By a number of different
criteria, this measure has now also been shown to be highly
responsive to clinical change in the context of hallux valgus
surgery. This study provides scale properties which can be
used to inform sample-size calculations for future trials. Fur-
ther work is needed to determine the extent of its suitability
as an outcome measure for other forms of foot and ankle
surgery.
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Appendix 1. The Manchester-Oxford foot questionnaire (MOXFQ)Please tick Circle as appropriate:
RIGHT / LEFT FOOT
1
During the past 4 weeks this
has applied to me:
None of
the time
Rarely
Some of
the time
Most of
the time
All of
the time
1. I have pain in my foot
2. I avoid walking long   
distances because of pain 
in my foot
3. I change the way I walk due
to pain in my foot
4. I walk slowly because of 
pain in my foot
5. I have to stop and rest my 
foot because of pain
6. I avoid some hard or rough 
surfaces because of pain in 
my foot
7. I avoid standing for a long 
time because of pain in my 
foot
8. I catch the bus or use the 
car instead of walking, 
because of pain in my foot
9. I feel self-conscious about 
my foot
10. I feel self-conscious about 
the shoes I have to wear
one  box for each statement
11. The pain in my foot is 
more painful in the evening
12. I get shooting pains in my foot
13. The pain in my foot prevents
me from carrying out my
work/everyday activities
14. I am unable to do all my
social or recreational  
activities because of pain
in my foot
15. During the past 4 weeks how would you describe the pain you usually have in
your foot? (please tick one box)
None SevereModerateMildVery mild
16. During the past 4 weeks have you been troubled by pain from your foot
in bed at night? (please tick one box)
Only 1 or 2 nights Some nights Most nightsNo nights Every night
1The foot to be assessed may be indicated here. Alternatively, each question may be customised to the right foot with all
questions then repeated and customised to the left foot.
Finally, please check that you have answered every question
Thank you very much
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